Literature DB >> 7161488

Strain restricted typing sera (SRTS) for use in monitoring the genetic integrity of congenic strains.

J S Arn, S E Riordan, D Pearson, D H Sachs.   

Abstract

A relatively simple procedure for serologic monitoring of the genetic integrity of congenic strains housed in a conventional colony is presented. Using a combination of 3 or 4 F1 immunizing cells, sera can be produced in each strain housed in the colony which will react in a complement-mediated cytotoxicity assay with peripheral lymphocytes from most if not all other strains in the colony. Routine screening of breeding stock with these strain restricted typing sera (SRTS) permits the sensitive detection of genetic contamination between the stocks maintained. These sera detect H-2, minor histocompatibility differences, and other cell surface differentiation antigens, and can also be used to identify the nature of a contaminant when isolated. In addition, when used within appropriate strain combinations, the sera can be useful in detecting antigenic determinants otherwise difficult to identify.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7161488     DOI: 10.1016/0022-1759(82)90027-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Seven new MHC recombinant strains defining new H-2 haplotypes.

Authors:  S L Epstein; J S Arn; D H Sachs
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Eight new MHC recombinant strains defining at least six H-2 haplotypes.

Authors:  S L Epstein; J S Arn; D H Sachs
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies.

Authors:  S O Sharrow; L Flaherty; D H Sachs
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

4.  Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.

Authors:  S T Ildstad; S M Wren; J A Bluestone; S A Barbieri; D H Sachs
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.